For over eight years, SeerPharma has partnered with the University of Technology Sydney (UTS), offering cutting-edge, university-accredited graduate programs on Good Manufacturing Practice (GMP). As the only course of its kind in the Asia-Pacific region, this collaboration underscores a commitment to advancing expertise in Quality/GMP within the pharmaceutical, biotechnology, and medical device sectors.
Our program is designed to provide participants with contemporary insights and a comprehensive understanding of good manufacturing practice (GMP) principles.
Attainment of a Master of Good Manufacturing Practice entails completion of 16 subjects, each spanning 10 weeks. Students obtain vital knowledge of legislative requirements pertinent to the registration, production, storage, and distribution of licensed therapeutic products. Furthermore, the curriculum delves into crucial facets such as GxP and quality systems compliance, alongside foundational concepts encompassing quality management, risk mitigation, aseptic techniques, supply chain dynamics, clinical trial protocols, and the intricate frameworks of quality assurance and quality control. These proficiencies serve as a strong foundation for those embarking on careers in Quality/GMP within our tightly regulated industry.
SeerPharma extends our congratulations to the latest cohort of students who have completed the rigorous Master of GMP program at UTS. We wish them every success in their forthcoming professional endeavours.
For more information on this unique program, do visit:
https://www.seerpharma.com/services/qa-and-gmp-training/university-postgraduate-gmp-training
